CAPTRUST Financial Advisors
BEAM icon

CAPTRUST Financial Advisors’s Beam Therapeutics BEAM Stock Holding History

CAPTRUST Financial Advisors’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,127
Closed -$44K – 2267
2022
Q2 		$44K Sell
1,127
-718
-39% -$28.5K ﹤0.01% 2841
2022
Q1 		$106K Buy
1,845
+425
+30% +$27.9K ﹤0.01% 2218
2021
Q4 		$113K Sell
1,420
-2,754
-66% -$236K ﹤0.01% 2066
2021
Q3 		$363K Buy
4,174
+832
+25% +$83.6K ﹤0.01% 1192
2021
Q2 		$430K Sell
3,342
-714
-18% -$56.9K ﹤0.01% 1051
2021
Q1 		$325K Buy
4,056
+3,076
+314% +$293K ﹤0.01% 1190
2020
Q4 		$80K Buy
980
+280
+40% +$13.8K ﹤0.01% 1607
2020
Q3 		$17K Hold
700
– – ﹤0.01% 2040
2020
Q2 		$20K Buy
+700
New +$15.1K ﹤0.01% 1933

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAPTRUST Financial Advisors's BEAM Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Beam Therapeutics (BEAM) in Q3 2022, closing a stake of 1,127 shares — an estimated $44K sold.

CAPTRUST Financial Advisors first reported a position in BEAM in Q2 2020 and held it in 9 quarters. The position peaked at $430K in Q2 2021. 224 funds tracked by Wall St. Rank hold BEAM as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Beam Therapeutics position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 1,127 Beam Therapeutics shares in Q3 2022, an estimated $44K.
  • CAPTRUST Financial Advisors first reported a position in Beam Therapeutics in Q2 2020 and held it in 9 quarters.
  • CAPTRUST Financial Advisors's Beam Therapeutics position peaked at $430K in Q2 2021.
  • 224 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.